ELIZABETH CZEREPAK

CIK 1263500 · See Remarks · last filed 2026-05-14

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

7

Total Filings

16

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DCTH Director $11.72 $0 7 2026-05-14
SCLXW See Remarks $0.17 $0 1 2023-01-17
SRNE EVP & Chief Financial Officer $0.00 $0 2 2022-05-20
SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Director 40,000 $1.03 $41.2K $0 2 2020-06-19
ALT CFO and EVP Corp. Development $2.61 $0 2 2017-09-26
Altimmune, Inc. (PIP) Delisted Director $0 1 2007-10-11
AFFYMAX INC (AFFY) Delisted Director $0 1 2007-05-31

Recent Filings · Page 2 of 2

16 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-06-19 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Grant (A) +30,000 $0 EDGAR
2019-07-02 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Grant (A) +10,000 $0 EDGAR
2017-09-26 ALT Grant (A) $0 EDGAR
2017-05-08 ALT Grant (A) $0 EDGAR
2007-10-11 Altimmune, Inc. (PIP) Delisted Grant (A) $0 EDGAR
2007-05-31 AFFYMAX INC (AFFY) Delisted Grant (A) $0 EDGAR
Showing 1116 of 16
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.